Asset Allocation & Management Company’s Bristol-Myers Squibb BMY Stock Holding History

Asset Allocation & Management Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,142	Closed	-$287K	–	69
2023 Q1	$287K	Hold	4,142	–	–	0.12%	79
2022 Q4	$298K	Sell	4,142 -1,571	-27%	-$118K	0.12%	89
2022 Q3	$406K	Hold	5,713	–	–	0.17%	75
2022 Q2	$440K	Sell	5,713 -8,569	-60%	-$653K	0.18%	73
2022 Q1	$1.04M	Hold	14,282	–	–	0.37%	53
2021 Q4	$890K	Buy	+14,282	New	+$838K	0.3%	71

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Asset Allocation & Management Company's BMY Position: Q2 2023 in Review

Asset Allocation & Management Company sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 4,142 shares — an estimated $287K sold.

Asset Allocation & Management Company first reported a position in BMY in Q4 2021 and held it in 6 quarters. The position peaked at $1.04M in Q1 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Asset Allocation & Management Company reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Asset Allocation & Management Company sold 4,142 Bristol-Myers Squibb shares in Q2 2023, an estimated $287K.
Asset Allocation & Management Company first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 6 quarters.
Asset Allocation & Management Company's Bristol-Myers Squibb position peaked at $1.04M in Q1 2022.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Asset Allocation & Management Company's 13F filing for Q2 2023, filed 8 Aug 2023.